Loading institutional data...
Loading institutional data...
Held by 149 of 2,417 reporting institutions (93th percentile) — extremely crowded.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Ranked against 19 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GWW | $64.6B | 38.8× | 23.6× | 3.6× | 4.5% | 39.1% | 9.5% | 45.7% | 27.4% | 0.7× | 410 |
| TEL | $64.0B | 36.2× | 16.9× | 3.7× | 8.9% | 35.2% | 10.7% | 14.6% | 10.1% | 1.1× | 375 |
| FERG | $46.5B | 25.8× | 16.8× | 1.5× | 3.8% | 30.7% | 6.0% | 31.8% | 18.6% | 1.2× | 237 |
| RS | $22.4B | 31.4× | 18.3× | 1.6× | 3.3% | — | 5.2% | 10.3% | 8.6% | 0.9× | 166 |
| SNX | $20.3B | 25.6× | 12.3× | 0.3× | 6.9% | 7.0% | 1.3% | 9.8% | 6.3% | 1.2× | 184 |
| WCC | $17.9B | 28.1× | 18.0× | 0.8× | 7.8% | 21.1% | 2.7% | 12.7% | 5.9% | 4.4× | 167 |
| GPC | $16.9B | 260.4× | 14.2× | 0.7× | 3.5% | 36.8% | 0.3% | 1.5% | 0.7% | 3.0× | 339 |
| WSO | $12.6B | 24.7× | 15.9× | 1.7× | -5.0% | 28.0% | 6.9% | 17.9% | 17.9% | -0.6× | 205 |
| ARW | $11.2B | 20.2× | 14.6× | 0.4× | 10.5% | 11.2% | 1.9% | 8.7% | 5.9% | 2.9× | 140 |
| AIT | $11.0B | 27.6× | 19.4× | 2.2× | 8.8% | 30.3% | 8.3% | 22.3% | 19.5% | 0.2× | 153 |
| HSIC | $9.6B | 26.4× | 10.6× | 0.7× | 4.0% | 31.1% | 3.0% | 12.3% | 9.9% | 0.6× | 149 |
| CNM | $8.1B | 19.1× | 11.0× | 1.1× | 2.8% | 26.9% | 5.8% | 22.1% | 10.6% | 2.1× | 85 |
| AVT | $7.6B | 23.1× | — | 0.3× | 24.5% | 10.4% | 1.2% | 6.7% | 4.1% | — | 138 |
| POOL | $7.3B | 18.8× | 13.6× | 1.4× | -0.4% | 29.7% | 7.7% | 34.3% | 17.0% | 1.9× | 117 |
| MSM | $6.9B | 30.9× | 18.0× | 1.7× | 6.4% | 40.9% | 5.6% | 15.6% | 11.7% | 1.0× | 113 |
| INGM | $6.6B | 20.6× | 7.4× | 0.1× | 9.5% | 6.7% | 0.6% | 7.7% | 4.4% | 1.2× | 33 |
| SITE | $4.8B | 32.9× | — | 1.0× | 3.6% | 34.8% | 3.2% | 9.1% | 7.4% | — | 74 |
| LKQ | $4.6B | 7.7× | 3.0× | 0.3× | -1.2% | 38.6% | 4.5% | 9.3% | 9.3% | -0.2× | 114 |
| REZI | $2.9B | — | 7.9× | 0.4× | 10.5% | 29.4% | -7.1% | -18.1% | -8.6% | 3.7× | 101 |
| DXPE | $2.7B | 32.8× | 17.4× | 1.4× | 11.9% | 31.5% | 4.4% | 17.8% | 6.7% | 2.8× | 61 |
Peers = companies sharing HSIC's sector (Wholesale-Medical, Dental & Hospital Equipment & Supplies) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $84.88 today, the market must believe free cash flow compounds 2.2%/yr for a decade (off $542.0M on the 3-yr avg basis).
On the basis ($503.0M) the requirement is 3.2%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 2.2% is more optimistic than its 9-yr track record.
Default is 7.9% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.11B shares (market data) · net debt $608.0M
mean 5.1% · volatility σ 39% · implied rate exceeded in 3/9 yrs
Central path = implied 2.2%/yr growth; shaded band = ±1σ (39%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $850.0M buybacks = $850.0M returned on $573.0M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Insufficient data. Current ROIC on all capital: 10%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it. This year they exceeded net income, so the ribbons are capped at earnings and understate what was actually returned.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.18B 100.0% | $12.67B 100.0% | $12.34B 100.0% | $12.65B 100.0% | $12.40B 100.0% | $10.12B 100.0% | $9.99B 100.0% | $13.20B 100.0% | $12.46B 100.0% | $11.57B 100.0% |
| Cost of Revenue | $9.08B 68.9% | $8.66B 68.3% | $8.48B 68.7% | $8.82B 69.7% | $8.73B 70.4% | $7.30B 72.2% | $6.89B 69.0% | $6.51B 49.3% | $6.14B 49.2% | $8.35B 72.1% |
| Gross Profit | $4.11B 31.1% | $4.02B 31.7% | $3.86B 31.3% | $3.83B 30.3% | $3.67B 29.6% | $2.82B 27.8% | $3.09B 31.0% | $2.91B 22.0% | $2.75B 22.0% | $3.23B 27.9% |
| Selling, General & Admin | $3.08B 23.4% | $3.03B 23.9% | $2.96B 24.0% | $2.77B 21.9% | $2.63B 21.2% | $2.09B 20.6% | $2.36B 23.6% | $2.22B 16.8% | $2.07B 16.6% | $2.41B 20.8% |
| Total Operating Expenses | — | — | — | — | — | — | — | $2.70B 20.5% | $2.53B 20.3% | $2.41B 20.8% |
| Operating Income | $653.0M 5.0% | $621.0M 4.9% | $615.0M 5.0% | $747.0M 5.9% | $852.0M 6.9% | $535.0M 5.3% | $718.3M 7.2% | $600.6M 4.5% | $669.8M 5.4% | $771.6M 6.7% |
| Interest Expense | $150.0M 1.1% | $131.0M 1.0% | $87.0M 0.7% | $35.0M 0.3% | $27.0M 0.2% | $41.0M 0.4% | $50.8M 0.5% | $76.0M 0.6% | $51.1M 0.4% | $31.9M 0.3% |
| Interest & Investment Income | $33.0M 0.3% | $24.0M 0.2% | $17.0M 0.1% | $8.0M 0.1% | $6.0M 0.0% | $10.0M 0.1% | $15.8M 0.2% | $15.5M 0.1% | $12.4M 0.1% | $13.3M 0.1% |
| Other Income (Expense), net | -$3.0M -0.0% | -$1.0M -0.0% | -$3.0M -0.0% | $1.0M 0.0% | $0 0.0% | -$4.0M -0.0% | -$2.9M -0.0% | -$3.3M -0.0% | -$1.3M -0.0% | $2.9M 0.0% |
| Pretax Income | $533.0M 4.0% | $513.0M 4.0% | $542.0M 4.4% | $721.0M 5.7% | $831.0M 6.7% | $500.0M 4.9% | $680.3M 6.8% | $536.8M 4.1% | $629.8M 5.1% | $755.8M 6.5% |
| Income Tax Expense | $126.0M 1.0% | $128.0M 1.0% | $120.0M 1.0% | $170.0M 1.3% | $198.0M 1.6% | $95.0M 0.9% | $159.5M 1.6% | $107.4M 0.8% | $309.0M 2.5% | $218.0M 1.9% |
| Net Income | $419.0M 3.2% | $398.0M 3.1% | $436.0M 3.5% | $566.0M 4.5% | $660.0M 5.3% | $404.0M 4.0% | $694.7M 7.0% | $535.9M 4.1% | $406.3M 3.3% | $506.8M 4.4% |
| Per Share | ||||||||||
| EPS (Basic) | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 | $4.70 | $3.51 | $2.59 | $3.14 |
| EPS (Diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | $2.57 | $3.10 |
| Weighted Avg Shares (Basic) | 120.8M | 126.8M | 130.6M | 136.1M | 140.1M | 142.5M | 147.8M | 152.7M | 156.8M | 161.6M |
| Weighted Avg Shares (Diluted) | 121.7M | 127.8M | 131.7M | 137.8M | 141.8M | 143.4M | 149.3M | 153.7M | 158.2M | 163.7M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $156.0M (at 2025-12-27) covers the $18.0M due within a year 8.7× over. Scheduled principal only (excludes interest & revolver draws). As of 2012-12-29 (10-K). The cash figure is from 2025-12-27, so the two are not the same balance-sheet date — the schedule has not been refiled since.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~19.6% on $764.0M of debt.
Cash of $156.0M is below short-term debt of $764.0M — relies on refinancing/operations.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-08 | 2 co-filers CEO, Global Dist. & Tech. | Tax withholding | 603 | $88.86 | $54k |
| 2026-09-08 | 2 co-filers CEO, Global Dist. & Tech. | Other | 3,984 | $0.00 | $0 |
| 2026-06-12 | Daniel William K Director | Grant | 2,215 | $0.00 | $0 |
| 2026-05-26 | Bergman Stanley M Insider | Gift |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
EOD close · as of 2026-10-30
Earns 3.02pts above its cost of capital, without much margin of safety.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2016 | 27.9% | 6.7% | 4.4% |
| FY2017 | 22.0% | 5.4% | 3.3% |
| FY2018 | 22.0% | 4.5% | 4.1% |
| FY2019 | 31.0% | 7.2% | 7.0% |
| FY2020 | 27.8% | 5.3% | 4.0% |
| FY2021 | 29.6% | 6.9% | 5.1% |
| FY2022 | 30.3% | 5.9% | 4.3% |
| FY2023 | 31.3% | 5.0% | 3.4% |
| FY2024 | 31.7% | 4.9% | 3.1% |
| FY2025 | 31.1% | 5.0% | 3.0% |
ROIC ex-goodwill is 169.17% against 10.93% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
| 50 |
| $0.00 |
| $0 |
| 2026-05-19 | Bergman Stanley M Director | Gift | 1,040 | $0.00 | $0 |
| 2026-05-11 | Daniel William K Director | Open-market buyindirect | 10,000 | $69.19 | $692k |
| 2026-03-19 | Popeck Thomas C CEO, Henry Schein Products | Open-market sale | 1,355 | $72.79 | $99k |
| 2026-03-17 | 3 co-filers EVP & Chief Operating Officer | Gift | 1,000 | $0.00 | $0 |
| 2026-03-16 | Popeck Thomas C CEO, Henry Schein Products | Tax withholding | 587 | $74.61 | $44k |
| 2026-03-16 | Sheehy Christine Zayac SVP, Chief Human Res. Officer | Tax withholding | 463 | $74.61 | $35k |
| 2026-03-16 | Albertini Andrea CEO, Global Dist. & Tech. | Tax withholding | 1,401 | $74.61 | $105k |
| 2026-03-16 | South Ronald N. SVP & Chief Financial Officer | Tax withholding | 5,216 | $74.61 | $389k |
| 2026-03-16 | 3 co-filers EVP & Chief Operating Officer | Gift | 1,300 | $0.00 | $0 |
| 2026-03-16 | Mlotek Mark E EVP, Chief Strategic Officer | Tax withholding | 5,928 | $74.61 | $442k |
| 2026-03-16 | 2 co-filers Group filing | Gift | 400 | $0.00 | $0 |
| 2026-03-16 | 2 co-filers Group filing | Tax withholding | 50 | $74.61 | $4k |
| 2026-03-16 | 3 co-filers EVP & Chief Operating Officer | Tax withholding | 4,214 | $74.61 | $314k |
| 2026-03-12 | Bergman Stanley M Director | Gift | 970 | $0.00 | $0 |
| 2026-03-10 | Kuehn Kurt P Director | Open-market sale | 2,844 | $78.96 | $225k |
| 2026-03-06 | 6 co-filers Group filing | Otherindirect | 918,723 | — | — |
| 2026-03-06 | Sheehy Christine Zayac SVP, Chief Human Res. Officer | Grant | 7,087 | $0.00 | $0 |
| 2026-03-06 | Popeck Thomas C CEO, Henry Schein Products | Grant | 53,206 | $0.00 | $0 |
| 2026-03-06 | Albertini Andrea CEO, Global Dist. & Tech. | Grant | 60,631 | $0.00 | $0 |
| 2026-03-06 | South Ronald N. SVP & Chief Financial Officer | Grant | 20,296 | $0.00 | $0 |
| 2026-03-06 | 2 co-filers CEO | Grant | 64,433 | $0.00 | $0 |
| 2026-03-06 | Ettinger Michael S EVP & Chief Operating Officer | Grant | 27,061 | $0.00 | $0 |
| 2026-03-06 | 2 co-filers EVP, Chief Strategic Officer | Gift | 300 | $0.00 | $0 |
| 2026-03-06 | 7 co-filers Group filing | Otherindirect | 918,723 | — | — |
| 2026-03-06 | Serota Scott Philip Director | Grant | 2,577 | $0.00 | $0 |
| 2026-03-06 | Faig Carole T Director | Grant | 2,577 | $0.00 | $0 |
| 2026-03-06 | Margulies Anne H. Director | Grant | 2,577 | $0.00 | $0 |
| 2026-03-06 | Ali Mohamad Director | Grant | 2,577 | $0.00 | $0 |
| 2026-03-06 | Tuckson Reed Vaughn Director | Grant | 2,577 | $0.00 | $0 |
| 2026-03-06 | Hombach Robert J. Director | Grant | 2,577 | $0.00 | $0 |
| 2026-03-06 | Kuehn Kurt P Director | Grant | 2,577 | $0.00 | $0 |
| 2026-03-06 | Derby Deborah Director | Grant | 2,577 | $0.00 | $0 |
| 2026-03-06 | Herring Joseph L Director | Grant | 2,577 | $0.00 | $0 |
| 2026-03-06 | Daniel William K Director | Grant | 2,577 | $0.00 | $0 |
| 2026-03-06 | Sheares Bradley T Director | Grant | 2,577 | $0.00 | $0 |
| 2026-03-06 | Laskawy Philip A Director | Grant | 2,577 | $0.00 | $0 |
Where each multiple sits in its own 14-yr range · 45th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 12% against ROIC 10% — 2% of the return on equity comes from leverage and buybacks rather than from the operating business.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Low operating leverage — profit tracks sales closely (stable, less cyclical).
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 49.3 | 69.0 | 72.2 | 70.4 | 69.7 | 68.7 | 68.3 | 68.9 |
| Gross Profit | 22.0 | 31.0 | 27.8 | 29.6 | 30.3 | 31.3 | 31.7 | 31.1 |
| SG&A | 16.8 | 23.6 | 20.6 | 21.2 | 21.9 | 24.0 | 23.9 | 23.4 |
| Operating Income | 4.5 | 7.2 | 5.3 | 6.9 | 5.9 | 5.0 | 4.9 | 5.0 |
| Income Tax | 0.8 | 1.6 | 0.9 | 1.6 | 1.3 | 1.0 | 1.0 | 1.0 |
| Net Income | 4.1 | 7.0 | 4.0 | 5.3 | 4.5 | 3.5 | 3.1 | 3.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on HSIC: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Leverage and buybacks account for 2 points of the 12% return on equity in FY2025. The business earns 10% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$4.3B of goodwill — 94% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer. With goodwill over half the base, the ex-goodwill figure divides by a small remainder and moves sharply — read it as a direction, not a precise rate.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2019 | 16.8% | 7.9% (today's — no rate published for this year) | 8.9pts |
| FY2020 | 11.6% | 7.9% (today's — no rate published for this year) | 3.7pts |
| FY2021 | 14.0% | 6.3% | 7.8pts |
| FY2022 | 11.5% | 7.9% | 3.6pts |
| FY2023 | 10.9% | 8.3% | 2.6pts |
| FY2024 | 10.8% | 8.3% | 2.5pts |
| FY2025 | 11.5% | 7.4% | 4.1pts |
| Now | 9.9% | 7.9% | 2.0pts |
Converts 1.20x of reported profit into free cash flow over 5 years, with accruals negative.
| Step | Amount | Running total |
|---|---|---|
| Net income | $398M | $398M |
| Share-based comp | $39M | $437M |
| Other non-cash & working capital | $275M | $712M |
| Operating cash flow | $712M | $712M |
| Capex | −$139M | $573M |
| Free cash flow | $573M | $573M |
| FCF after SBC | $534M | $534M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 1.3% | 14.3% | 13.0 points |
| FY2021 | 22.6% | 1.9% | -20.6 points |
| FY2022 | 2.0% | -0.7% | -2.7 points |
| FY2023 | -2.4% | 29.2% | 31.6 points |
| FY2024 | 2.7% | -20.4% | -23.2 points |
| FY2025 | 4.0% | 11.4% | 7.4 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 45.6 days | 75.6 days | 46.6 days | 74.6 days |
| FY2020 | 51.4 days | 75.6 days | 50.3 days | 76.7 days |
| FY2021 | 42.7 days | 77.8 days | 44.1 days | 76.5 days |
| FY2022 | 41.6 days | 81.3 days | 41.6 days | 81.3 days |
| FY2023 | 55.1 days | 78.1 days | 43.9 days | 89.3 days |
| FY2024 | 42.7 days | 76.3 days | 40.6 days | 78.4 days |
| FY2025 | 45.7 days | 80.5 days | 46.4 days | 79.8 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | 0.6 percent |
| FY2020 | -2.5 percent |
| FY2021 | -0.9 percent |
| FY2022 | -0.7 percent |
| FY2023 | -0.8 percent |
| FY2024 | -4.5 percent |
| FY2025 | -2.8 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 7 consecutive years to the latest.
Capex has been below depreciation for 7 consecutive years (0.47x on average over the last 5). Spending less than the asset base is consuming flatters free cash flow now and defers the cost — though depreciation also covers amortisation of acquired intangibles, which capex is not meant to replace.
Covers interest 3.0x under stress — adequate, without much room.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 4.35x |
| 5% | 4.14x |
| 10% | 3.92x |
| 15% | 3.70x |
| 20% | 3.48x |
| 25% | 3.27x |
| 30% | 3.05x |
| 35% | 2.83x |
| 40% | 2.61x |
| 45% | 2.39x |
| 50% | 2.18x |
| 55% | 1.96x |
| 60% | 1.74x |
This schedule comes from a filing dated 2012-12-29, 5053 days old. Maturities are shown relative to that date, not to today.
Ladder as of 2012-12-29 (10-K); cash from the 2025-12-27 balance sheet; FCF from FY2025.
Balance sheet at 2025-12-27. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
Coverage is comfortable at 4.3x today but falls to 3.0x after a 30% EBITDA decline — the cushion is earnings, not liquidity.
At $86.44, free cash flow must compound 2.85%/yr for 10 years. It has done -0.14%/yr over 6 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2020 | −4.8% | 2.9% |
| FY2021 | 14.7% | 2.9% |
| FY2022 | −19.8% | 2.9% |
| FY2023 | −30.2% | 2.9% |
| FY2024 | 98.3% | 2.9% |
| FY2025 | −18.1% | 2.9% |
The percentile ranks the FISCAL-YEAR point, because the distribution behind each strip is built from fiscal-year closes — ranking a TTM figure inside it would compare two different bases. TTM basis: TTM.
The implied rate has been matched or beaten in 2 of the last 6 years.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.